Sugarloaf Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$76K Hold
2,864
0.01% 252
2024
Q3
$82.9K Sell
2,864
-2,487
-46% -$72.5K 0.02% 249
2024
Q2
$150K Sell
5,351
-300
-5% -$8.26K 0.03% 192
2024
Q1
$157K Sell
5,651
-336
-6% -$9.32K 0.03% 184
2023
Q4
$172K Sell
5,987
-101
-2% -$3.05K 0.04% 162
2023
Q3
$202K Sell
6,088
-165
-3% -$5.83K 0.05% 126
2023
Q2
$229K Sell
6,253
-493
-7% -$19.2K 0.05% 115
2023
Q1
$275K Sell
6,746
-143
-2% -$6.18K 0.07% 106
2022
Q4
$353K Sell
6,889
-1,038
-13% -$49.8K 0.09% 89
2022
Q3
$347K Buy
7,927
+675
+9% +$32.8K 0.09% 91
2022
Q2
$380K Sell
7,252
-53
-0.7% -$2.7K 0.1% 86
2022
Q1
$378K Buy
7,305
+7
+0.1% +$363 0.09% 84
2021
Q4
$431K Buy
7,298
+47
+0.6% +$2.33K 0.1% 77
2021
Q3
$312K Sell
7,251
-1,347
-16% -$59.7K 0.08% 100
2021
Q2
$337K Sell
8,598
-729
-8% -$28.3K 0.09% 91
2021
Q1
$338 Buy
9,327
+2,288
+33% +$81.2K 0.1% 87
2020
Q4
$259K Sell
7,039
-4,299
-38% -$158K 0.09% 96
2020
Q3
$395K Sell
11,338
-17
-0.1% -$596 0.14% 72
2020
Q2
$352K Sell
11,355
-4
-0% -$136 0.14% 80
2020
Q1
$352K Sell
11,359
-595
-5% -$20.3K 0.16% 78
2019
Q4
$444K Buy
+11,954
New +$426K 0.19% 82

Other funds holding PFE

Sugarloaf Wealth Management's PFE Position: Q4 2024 in Review

Sugarloaf Wealth Management held its Pfizer (PFE) position steady in Q4 2024 at 2,864 shares worth $76K. The position accounts for 0.01% of the portfolio, ranked #252.

Sugarloaf Wealth Management first reported a position in PFE in Q4 2019 and has held it in 21 quarters since. The position peaked at $444K in Q4 2019. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Sugarloaf Wealth Management held 2,864 shares of Pfizer worth $76K as of Q4 2024.
  • Sugarloaf Wealth Management left its Pfizer share count unchanged in Q4 2024.
  • Pfizer made up 0.01% of Sugarloaf Wealth Management's portfolio in Q4 2024, its #252 holding.
  • Sugarloaf Wealth Management first reported a position in Pfizer in Q4 2019 and has held it in 21 quarters since.
  • Sugarloaf Wealth Management's Pfizer position peaked at $444K in Q4 2019.
  • 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Sugarloaf Wealth Management's 13F filing for Q4 2024, filed 10 Jan 2025.